Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Psoriatic Arthritis Therapeutics Market: By Drug Class: TNF Inhibitors, Interleukin Inhibitors, PDE4 Inhibitors; By Route of Administration: Oral, Parenteral, Topical; By Distribution Channel; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Psoriatic Arthritis Therapeutics Market Outlook

The global psoriatic arthritis therapeutics market is projected to grow at a CAGR of 6.5% in the forecast period of 2021-2026.

 

The market growth is being driven by the growing health awareness among the consumers. North America is leading the regional market in the industry as a result of the increasing demand for the product, especially, from the United States.

 

Global Psoriatic Arthritis Therapeutics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Properties and Applications

Psoriatic arthritis is a chronic disease associated with psoriasis. The condition needs timely treatment, the absence of which may lead to irreversible joint damage.

The psoriatic arthritis therapeutics market can be broadly categorised based on drug class, route of administration, and distribution channel.

 

Global Psoriatic Arthritis Therapeutics Market By Distribution Channel

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on the drug class, the industry can be segmented into:

  • TNF Inhibitors
  • Interleukin Inhibitors
  • PDE4 Inhibitors
  • Others

Based on the route of administration, the industry can be divided into:

  • Oral
  • Parenteral
  • Topical

Based on the distribution channel, the market can be divided into:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

The EMR report looks into the regional markets of psoriatic arthritis therapeutics like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Psoriatic Arthritis Therapeutics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The global psoriatic arthritis therapeutics market is being driven by the launch of new products, the increasing prevalence of psoriatic arthritis, and the growing consumer awareness regarding their health. Interleukin inhibitors are leading the drug class segment due to the rising emergence of biosimilars. North America, along with Europe, held more than half the overall market revenue in 2020 owing to rising commercial sales of products in the United States, the presence of key players, initiatives undertaken by the governments, the enactment of favourable policies, and the increasing incidence of psoriatic arthritis. The Asia Pacific is estimated to witness the fastest growth in the forecast period as a result of the increasing disposable income of consumers, improvement in healthcare facilities, economic growth, and the rising adoption of biosimilars in emerging markets such as China, India, and South Korea.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global psoriatic arthritis therapeutics market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • AbbVie, Inc. (NYSE: ABBV)
  • Janssen Global Services LLC (Johnson & Johnson)
  • Novartis AG 
  • Amgen, Inc. 
  • Celgene Corporation 
  • Pfizer, Inc. 
  • Eli Lilly and Company 
  • UCB SA. 
  • Biogen Inc. 
  • Bristol-Myers Squibb Company

The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2016-2020
Forecast Period 2021-2026
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Drug Class, Route of Administration, Distribution Channel, Region
Breakup by Drug Class TNF Inhibitors, Interleukin Inhibitors, PDE4 Inhibitors, Others
Breakup by Route of Administration Oral, Parenteral, Topical
Breakup by Distribution Channel Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered AbbVie, Inc. (NYSE: ABBV), Janssen Global Services LLC (Johnson & Johnson),
Novartis AG (SWX: NOVN), Amgen, Inc. (NASDAQ: AMGN), Celgene Corporation
(NASDAQ: CELG), Pfizer, Inc. (NYSE: PFE), Eli Lilly and Company (NYSE: LLY),
UCB SA. (EBR: UCB), Biogen Inc. (NASDAQ: BIIB), Bristol-Myers Squibb Company (NYSE: BMY)
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Psoriatic Arthritis Therapeutics Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Psoriatic Arthritis Therapeutics Historical Market (2016-2020) 
    8.3    Global Psoriatic Arthritis Therapeutics Market Forecast (2021-2026)
    8.4    Global Psoriatic Arthritis Therapeutics Market by Drug Class
        8.4.1    TNF Inhibitors
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2016-2020)
            8.4.1.3    Forecast Trend (2021-2026)
        8.4.2    Interleukin Inhibitors
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2016-2020)
            8.4.2.3    Forecast Trend (2021-2026)
        8.4.3    PDE4 Inhibitors
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2016-2020)
            8.4.3.3    Forecast Trend (2021-2026)
        8.4.4    Others
    8.5    Global Psoriatic Arthritis Therapeutics Market by Route of Administration
        8.5.1    Oral
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2016-2020)
            8.5.1.3    Forecast Trend (2021-2026)
        8.5.2    Parenteral
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2016-2020)
            8.5.2.3    Forecast Trend (2021-2026)
        8.5.3    Topical
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2016-2020)
            8.5.3.3    Forecast Trend (2021-2026)
    8.6    Global Psoriatic Arthritis Therapeutics Market by Distribution Channel
        8.6.1    Hospital Pharmacies
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2016-2020)
            8.6.1.3    Forecast Trend (2021-2026)
        8.6.2    Retail Pharmacies
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2016-2020)
            8.6.2.3    Forecast Trend (2021-2026)
        8.6.3    Online Pharmacies
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2016-2020)
            8.6.3.3    Forecast Trend (2021-2026)
    8.7    Global Psoriatic Arthritis Therapeutics Market by Region
        8.7.1    Market Share
            8.7.1.1    North America
            8.7.1.2    Europe
            8.7.1.3    Asia Pacific
            8.7.1.4    Latin America
            8.7.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2016-2020)
        9.1.2    Forecast Trend (2021-2026)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2016-2020)
        9.2.2    Forecast Trend (2021-2026)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2016-2020)
        9.3.2    Forecast Trend (2021-2026)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2016-2020)
        9.4.2    Forecast Trend (2021-2026)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2016-2020)
        9.5.2    Forecast Trend (2021-2026)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    AbbVie Inc.
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Janssen Global Services, LLC (Johnson & Johnson)
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Novartis AG
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Amgen Inc.
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Biogen Inc.  
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Pfizer Inc.
            12.2.6.1    Company Overview
            12.2.6.2    Product Portfolio
            12.2.6.3    Demographic Reach and Achievements
            12.2.6.4    Certifications
        12.2.7    Others
13    Industry Events and Developments


List of Figures and Tables

1.    Global Psoriatic Arthritis Therapeutics Market: Key Industry Highlights, 2016 and 2026
2.    Global Psoriatic Arthritis Therapeutics Historical Market: Breakup by Drug Class (USD Million), 2016-2020
3.    Global Psoriatic Arthritis Therapeutics Market Forecast: Breakup by Drug Class (USD Million), 2021-2026
4.    Global Psoriatic Arthritis Therapeutics Historical Market: Breakup by Route of Administration (USD Million), 2016-2020
5.    Global Psoriatic Arthritis Therapeutics Market Forecast: Breakup by Route of Administration (USD Million), 2021-2026
6.    Global Psoriatic Arthritis Therapeutics Historical Market: Breakup by Distribution Channel (USD Million), 2016-2020
7.    Global Psoriatic Arthritis Therapeutics Market Forecast: Breakup by Distribution Channel (USD Million), 2021-2026
8.    Global Psoriatic Arthritis Therapeutics Historical Market: Breakup by Region (USD Million), 2016-2020
9.    Global Psoriatic Arthritis Therapeutics Market Forecast: Breakup by Region (USD Million), 2021-2026
10.    North America Psoriatic Arthritis Therapeutics Historical Market: Breakup by Country (USD Million), 2016-2020
11.    North America Psoriatic Arthritis Therapeutics Market Forecast: Breakup by Country (USD Million), 2021-2026
12.    Europe Psoriatic Arthritis Therapeutics Historical Market: Breakup by Country (USD Million), 2016-2020
13.    Europe Psoriatic Arthritis Therapeutics Market Forecast: Breakup by Country (USD Million), 2021-2026
14.    Asia Pacific Psoriatic Arthritis Therapeutics Historical Market: Breakup by Country (USD Million), 2016-2020
15.    Asia Pacific Psoriatic Arthritis Therapeutics Market Forecast: Breakup by Country (USD Million), 2021-2026
16.    Latin America Psoriatic Arthritis Therapeutics Historical Market: Breakup by Country (USD Million), 2016-2020
17.    Latin America Psoriatic Arthritis Therapeutics Market Forecast: Breakup by Country (USD Million), 2021-2026
18.    Middle East and Africa Psoriatic Arthritis Therapeutics Historical Market: Breakup by Country (USD Million), 2016-2020
19.    Middle East and Africa Psoriatic Arthritis Therapeutics Market Forecast: Breakup by Country (USD Million), 2021-2026
20.    Global Psoriatic Arthritis Therapeutics Market Structure

Key Questions Answered in the Report

The global psoriatic arthritis therapeutics market is projected to grow at a CAGR of 6.5% between 2021 and 2026.

The major drivers of the industry include the increasing disposable income of consumers, improvement in healthcare facilities, economic growth, the rising adoption of biosimilars in emerging markets, the increasing prevalence of psoriatic arthritis, the growing consumer awareness regarding their health, and growing technological advancements.

The key market trend guiding the growth of the industry include the launch of new products.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America accounting for the largest share in the market.

TNF inhibitors, interleukin inhibitors, and PDE4 inhibitors, among others are the major drug class of psoriatic arthritis therapeutics in the industry.

Oral, parenteral, and topical are the significant routes of administration of the product in the industry.

Hospital pharmacies, retail pharmacies, and online pharmacies are the significant distribution channels of psoriatic arthritis therapeutics.

The major players in the industry are AbbVie, Inc., Janssen Global Services LLC (Johnson & Johnson), Amgen Inc., Pfizer, Inc., Biogen Inc., and Novartis AG, among others.

Analyst Review

The global psoriatic arthritis therapeutics market is driven by the improvement in healthcare facilities and the rising adoption of biosimilars in emerging markets. Aided by the technological advancements, the market is expected to witness a further growth in the forecast period of 2021-2026, growing at a CAGR of 6.5%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its drug class segments, the industry can be segmented into TNF inhibitors, interleukin inhibitors, and PDE4 inhibitors, among others. On the basis of route of administration, the industry is categorised into oral, parenteral, and topical. On the basis of distribution channels, the industry is divided into hospital pharmacies, retail pharmacies, and online pharmacies. The major regional markets for psoriatic arthritis therapeutics are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with North America accounting for the largest share of the market. The key players in the above market include A AbbVie, Inc., Janssen Global Services LLC (Johnson & Johnson), Amgen Inc., Pfizer, Inc., Biogen Inc., and Novartis AG, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER